A Comparative View on Human Somatic Cell Sources for iPSC Generation
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
The breakthrough of reprogramming human somatic cells was achieved in 2006 by the work of Yamanaka and Takahashi. From this point, fibroblasts are the most commonly used primary somatic cell type for the generation of induced pluripotent stem cells (iPSCs). Various characteristics of fibroblasts supported their utilization for the groundbreaking experiments of iPSC generation. One major advantage is the high availability of fibroblasts which can be easily isolated from skin biopsies. Furthermore, their cultivation, propagation, and cryoconservation properties are uncomplicated with respect to nutritional requirements and viability in culture. However, the required skin biopsy remains an invasive approach, representing a major drawback for using fibroblasts as the starting material. More and more studies appeared over the last years, describing the reprogramming of other human somatic cell types. Cells isolated from blood samples or urine, as well as more unexpected cell types, like pancreatic islet beta cells, synovial cells, or mesenchymal stromal cells from wisdom teeth, show promising characteristics for a reprogramming strategy. Here, we want to highlight the advantages of keratinocytes from human plucked hair as a widely usable, noninvasive harvesting method for primary material in comparison with other commonly used cell types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reprogramming efficiency is also higher for these two cell types and requires relatively less time for reprogramming [11,12].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299 · cited 1×
“On the other hand, its oncogenic potential suggests its omission for clinical applications [19].”
BackgroundHematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
Epigenetic memory in induced pluripotent stem cells
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., et al. (2010) · Nature · doi:10.1038/nature09342 · Cited by 2,313 · cited 1×
“the epigenetic memory after prolonged iPS cell culture which leads to the conclusion that the primary cell source may not be absolutely essential for redifferentiation [34, 35].”
BackgroundGeneration of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009 · cited 2×
“Moreover, also these systems exhibit a low reprogramming efficiency compared to other systems [10, 21].”
BackgroundMethodGeneration of Induced Pluripotent Stem Cells Using Recombinant Proteins
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788
Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606 · cited 1×
“To avoid the use of integrating viruses, other reprogramming approaches, for example, the use of Sendai viruses [9], plasmids [10], modified RNA [11], or small molecules [12, 13], have been described.”
MethodHotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G., Antosiewicz-Bourget, J., O’Malley, R., Castanon, R., Klugman, S., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,549 · cited 1×
“The general reprogramming process changes the transcriptome and chromatin state of the somatic cell to that of a pluripotent cell [24].”
Background
Cited by
Items 201–262 of 262
Stem Cells Advancement and Applications: A Regenerative Medicines
Thakur, P., Nirmala, Kaur, J., Kaushal, P., Bhardwaj, A., & Pandit, V. R. (2025) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v15i2.6979 · Cited by 2
Dong, S., Chen, J., Li, S., Li, Y., Liang, X., Liu, Y., Zhang, M., Yang, F., Feng, R., & Liang, J. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2024.05.014 · Cited by 1
Aguilera, C., Wong, Y. S., Echeverry, D., Veraguas, D., & Cartes, D. A. (2026) · Annals of Animal Science · doi:10.2478/aoas-2025-0073 · Cited by 1
“In contrast, more specialized cells may exhibit “cellular memory” due to epigenetic modifications from differentiation and aging, making it hard - er for them to revert to a pluripotent state (Mali et al., 2008; Easley IV et al., 2012; Wang et al., 2012; Raab et al., 2014).”
InfluentialModeling rare genetic skeletal disorders with bone organoids: a narrative review
Micha, D., Quirós, S. E., Eekhoff, E. M. W., Heine, V. M., Shim, J., & Zhytnik, L. (2026) · Bone · doi:10.1016/j.bone.2026.117799 · Cited by 1
Early selection of human fibroblast-derived induced pluripotent stem cells
Stoyanova, E., Mourdjeva, M., & Kyurkchiev, S. (2015) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2015.1052015 · Cited by 1
“Also, fibroblast cultivation and cryoconservation properties are uncomplicated with respect to nutritional requirements and viability in culture.[5] The results from the co-transfection of the fibroblasts with four plasmids, coding OCT4, SOX2, C-MYC and KLF4, produced in 293T/17 cells, are shown in Figure 1.”
BackgroundStem Cells Commitment on Graphene-Based Scaffolds
Buggio, M., Tatullo, M., Sivolella, S., Gardin, C., Ferroni, L., Mijiritsky, E., Piattelli, A., & Zavan, B. (2016) · Carbon nanostructures · doi:10.1007/978-3-319-45639-3_4 · Cited by 1
Xeno-free cultivation of human induced pluripotent stem cells for clinical applications
Saleh, F., Mondeh-Lowor, R., & de Peppo, G. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85766-6.00001-2 · Cited by 1
Induced pluripotent stem cells for modeling open-angle glaucoma
Cheuk, B. S., Kumar, A., & Du, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823882-0.00001-1 · Cited by 1
Lim, Y., Cheong, S. K., & Leong, P. P. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10855-2 · Cited by 2
“…non-blood-derived hiPSC, such as those originating from fibroblasts, to derive haematopoietic cells for clinical application would be a better option, as fibroblasts can be easily obtained, propagated in vitro, and possess a 10–50 times higher reprogramming efficiency than blood cells [ 10, 11 ].”
Urine-Derived Stem Cells: A New Class of Stem Cells in Treatment of Neurodegenerative Disorders
Raad, R. K., Rafiei, S., Malekzadeh, S., & Edalatmanesh, M. A. (2017) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.5.1.87 · Cited by 1
Induced pluripotent stem cell derived from postmortem tissue in neurodegenerative disease research
Rogers, J., Myers, A., & Dykxhoorn, D. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822135-8.00008-2 · Cited by 1
Andrianto, A., Basworo, A., Dewi, I. P., & Pikir, B. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.13.422599 · Cited by 1
“Peripheral blood cells have become an attractive source of iPSCs because they are easy to extract, minimally invasive and can be preserved in a frozen state [4].”
BackgroundSaygılı, G., Türktaş, M., Gürcan, C., Delogu, L. G., & Yılmazer, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.18.500480 · Cited by 1
Induced Pluripotent Stem-cell Lines in the Clinic - Still a Long Road Ahead
Bhatt, S. (2015) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2015.02.00044
“But the methods of gene delivery to induce pluripotency while generating iPSCs have often come under scrutiny owing to the concerns on genomic alterations that some methods involve that renders them unsuitable for clinical applications in humans [11-35].”
BackgroundAPLIKASI SEL iPSC SEBAGAI KANDIDAT TERAPI ADJUVAN REMODELING JANTUNG PASKA INFARK MIOKARD AKUT
Winardi, W. (2015) · Jurnal Natural (Faculty of Mathematics and Natural Science, Syiah Kuala University)
The Promoting Equity in Stem Cell Genomics Survey
Fakunle, E. S., Glenn-Pratola, V., Peterson, S. E., Loring, J. F., & Madanat, H. N. (2022) · Regenerative Medicine · doi:10.2217/rme-2021-0081
Pessôa, L. V. D. F. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2017.tde-22032017-120120
Dental application of the induced pluripotent stem cells in stomatology
Kuznetsova, L. V., Malyshev, I. Y., & Yanushevich, O. O. (2017) · Russian Journal of Stomatology · doi:10.17116/rosstomat201710249-57
Eren, E., Erkan, E. P., Genç, Ş., & Genc, K. K. (2017) · Stem cells in clinical applications · doi:10.1007/978-3-319-59165-0_2
“To date, different cells have been used as source for iPSCs, such as primary hepatocytes, exfoliated renal epithelial cells, umbilical cord and peripheral blood cells, keratinocytes (Raab et al. 2014), pancreatic β cells (Stadtfeld et al.”
Modelling the neurobiology of Alzheimer’s disease in vitro
Muñoz, S. S. (2019) · Research Online (University of Wollongong)
Wulkan, F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-07082019-104943
Metabolic phenotyping of the pressure-overloaded heart: Focus on model development
Geraets (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200124ig
Aprihati, A., Pikir, B. S., & Andrianto, A. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.3862
“Peripheral blood cells were one of the attractive sources of iPSCs because easy to collect, minimally invasive, and can be stored in a frozen form [4].”
BackgroundNeuropharmacology: Looking Forward to the Future
Siju, E. N., & Rajalakshmi, G. R. (2020) · Springer eBooks · doi:10.1007/978-981-15-5167-3_10
Induced pluripotent stem cells in periodontal regeneration - Narrative review
Pradeep, K. Y., Madhuri, B., Ravishankar, P. L., Rajapandain, K., Kalaivani, V., & Chopra, P. (2020) · Journal of Surgery Peridontology and Implant Research · doi:10.35252/jspir.2020.1.002.1.06
Zhao, W., Garza, J. C., Perlis, R. H., & Haggarty, S. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00014-4 · Cited by 1
iPSCs for modeling coxsackievirus infection
Belkaya, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823808-0.00004-3
Halonen, S. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823808-0.00010-9 · Cited by 1
Crestani, T. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-23062021-114831
Wu, J. F., Gao, J., Zhang, S., Luo, T., Dai, W., Ling, J., & Wang, J. (2020) · Research Square · doi:10.21203/rs.2.21232/v1
McAndrews, K. M., McGrail, D. J., Gansmo, L. B., Che, S. P. Y., Chakravarti, D., LeBleu, V. S., & Kalluri, R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.18.504466
“Normal fibroblasts are considered to have low epigenetic drifts [27] and can withstand manipulation associated with transfection reagents and viral infection to generate iPSCs [26].”
BackgroundInduced Pluripotent Stem Cells: Progress toward Clinical Translation from Bench to Bedside
Fakoya, A. O. J., Omole, A. E., Satyadev, N., & Haider, K. H. (2022) · Springer eBooks · doi:10.1007/978-981-19-2655-6_40
Ali, H. R. W., Suliman, S., Osman, T., Carrasco, M., Bruland, O., Costea, D. E., Ræder, H., & Mustafa, K. (2023) · Research Square · doi:10.21203/rs.3.rs-2187505/v1
Induzierte pluripotente Stammzellen in der pädiatrischen Forschung und klinischen Umsetzung
Uçkan, D., & Haider, K. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-25378-2_13
Induced Pluripotent Stem Cells in Epithelial Lamellar Keratoplasty
Bojić, S., Figueiredo, F. C., & Lako, M. (2023) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-031-32408-6_16
Modelling phenotypes, variants and pathomechanisms of syndromic diseases in different systems
Gregor, A., & Zweier, C. (2024) · Medizinische Genetik · doi:10.1515/medgen-2024-2020 · Cited by 1
“Other starting tissues that have been used successfully include peripheral or umbilical cord blood cells, where CD34+ are isolated, keratinocytes from hair and tubular epithelial cells isolated from urine samples [81].”
BackgroundMoerkens, R., Mooiweer, J., Smits, E., Berg, M., Ramírez-Sánchez, A. D., Modderman, R., Puschhof, J., Pleguezuelos‐Manzano, C., Barrett, R. J., Wijmenga, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.30.601390
“In contrast to ASC-derived tissues, which rely on invasive procedures to collect human intestinal material, hiPSCs can be created from easily accessible somatic cells from blood, skin or even urine 6 .”
BackgroundHow human-induced pluripotent stem cells are derived into organoids
Babu, H. W. S., Ilangovan, N., MuthuKumar, S., Faris, S., Ram, H., & Ravimanickam, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29898-1.00018-6
Klingenstein, S., Boenke, J., Wüstner, L.-S., Liebau, S., & Klingenstein, M. (2025) · PeerJ · doi:10.7717/peerj.20214
“Plucked HFs, particularly ORS cells, provide, a non-invasive source of keratinocytes ( Raab et al., 2014 ).”
Self-citationMartín-López, M., Rosell‐Valle, C., Arribas-Arribas, B., Fernández‐Muñoz, B., Jiménez, R., Nogueras, S., García-Delgado, A. B., Campos, F., & González, M. S. (2024) · Figshare · doi:10.6084/m9.figshare.26581082
Martín-López, M., Rosell‐Valle, C., Arribas-Arribas, B., Fernández‐Muñoz, B., Jiménez, R., Nogueras, S., García-Delgado, A. B., Campos, F., & González, M. S. (2024) · Figshare · doi:10.6084/m9.figshare.26581088
Martín-López, M., Rosell‐Valle, C., Arribas-Arribas, B., Fernández‐Muñoz, B., Jiménez, R., Nogueras, S., García-Delgado, A. B., Campos, F., & González, M. S. (2024) · Figshare · doi:10.6084/m9.figshare.26581094
Martín-López, M., Rosell‐Valle, C., Arribas-Arribas, B., Fernández‐Muñoz, B., Jiménez, R., Nogueras, S., García-Delgado, A. B., Campos, F., & González, M. S. (2024) · Figshare · doi:10.6084/m9.figshare.26581076
Cho, Y. K., Kim, H.-K., Kwon, S. S., Jeon, S.-H., Cheong, J.-W., Nam, K. T., Kim, H.-S., Kim, S., & Kim, H. O. (2024) · Figshare · doi:10.6084/m9.figshare.26585247
Martín-López, M., Rosell‐Valle, C., Arribas-Arribas, B., Fernández‐Muñoz, B., Jiménez, R., Nogueras, S., García-Delgado, A. B., Campos, F., & González, M. S. (2024) · Figshare · doi:10.6084/m9.figshare.26581079
Martín-López, M., Rosell‐Valle, C., Arribas-Arribas, B., Fernández‐Muñoz, B., Jiménez, R., Nogueras, S., García-Delgado, A. B., Campos, F., & González, M. S. (2024) · Figshare · doi:10.6084/m9.figshare.26581085
Martín-López, M., Rosell‐Valle, C., Arribas-Arribas, B., Fernández‐Muñoz, B., Jiménez, R., Nogueras, S., García-Delgado, A. B., Campos, F., & González, M. S. (2024) · Figshare · doi:10.6084/m9.figshare.26581091
Klingenstein, S., Hollweg, N. M., Liebau, S., & Klingenstein, M. (2026) · Cells Tissues Organs · doi:10.1159/000550296 · Cited by 1
Self-citationAljuid, L. M., Alyousfi, D., Hosawi, M., & Elsamanoudy, A. Z. (2026) · Archives of Stem Cell and Therapy · doi:10.46439/stemcell.6.026
From mice to clinical relevance: humanizing neuroscience with human-based model systems
Bak, A., van Loo, K. M. J., Kronenberg‐Versteeg, D., & Koch, H. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1776439
“…could also be generated from human dermal fibroblasts using the same four transcription factors (Takahashi et al., 2007), opening new avenues for research. iPSCs offer numerous advantages, including easy isolation from accessible adult cell types like skin, blood, and urine cells (Raab et al., 2014).”
Lin, X., & Bui, T. V. A. (2026) · Cytotherapy · doi:10.1016/j.jcyt.2026.102815
Reprogramming Induced Pluripotent Stem Cell Lines from Frozen Buffy Coat Samples
Art, J., James, C., Dalal, B., Fantone, K. M., Rada, B., Felner, E. I., González‐Duarte, A., Michopoulos, V., Corneo, B., & Zeltner, N. (2026) · Journal of Visualized Experiments · doi:10.3791/70522
Fayyad, M., Fatehi, A., Samuel, S., Han, D., Sathyanarayanan, A., Christie, K., Ahmed, N., Rogers, I. M., & Taylor, D. W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104183
Roychowdhury, S., Thamodaran, V., Joshi, D., & Das, P. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.731103
“PBMNCs were selected as the somatic cell source due to their minimally invasive collection procedure and high reprogramming efficiency, which make them a preferable alternative to the more commonly used skin fibroblasts for iPSC cultures[19].”
Vincze, K., Varga, N., Tóth, S., Kis, A. K., Béres, R., Réthelyi, J., Veréb, Z., Erdei, Z., Sarkadi, B., & Apáti, Á. (2026) · Pathology & Oncology Research · doi:10.3389/pore.2026.1612490
“Umbilical cord blood-derived cells are biologically young, exhibiting high telomerase activity [22], fewer somatic mutations [16, 23], and a “naïve” epigenetic state that facilitates high reprogramming efficiency [24].”
Cheng, I. Q., Ruiz, J. F., Casalino, E. K., Zhang, C., & Louvi, A. (2026) · Nature Protocols · doi:10.1038/s41596-026-01440-z
Metadata
- Authors
- Raab, S., Klingenstein, M., Liebau, S., & Linta, L.
- Affiliations
- University of Tübingen (DE)
- Corresponding author
- Liebau, Stefan
- Linta, Leonhard
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-12
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- PMC
- PMC4241335
- OpenAlex
- W2034460442
- Cited by
- 263
- References
- 83
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 28 · 2023: 21 · 2022: 20 · 2021: 35 · 2020: 27 · 2019: 26 · 2018: 19 · 2017: 21 · 2016: 22 · 2015: 7
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Stem Cells International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (DFG, SL BO1718/4-1, F/34/11, 2011 A200)
- German Foundation for Heart Research (DFG, SL BO1718/4-1, F/34/11, 2011 A200)
- Else Kröner-Fresenius-Stiftung (DFG, SL BO1718/4-1, F/34/11, 2011 A200)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, somatic cell reprogramming, keratinocytes, hair follicle, fibroblasts, urine-derived cells, pancreatic beta cells, synoviocytes, mesenchymal stem cells, skin biopsy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.